


Human Promyelocytic Leukemia Protein (PML)
SIZE
0.1 mg
INTRODUCTION
Key component of PML nuclear bodies that regulate a large number of cellular processes by facilitating post-translational modification of target proteins, promoting protein-protein contacts, or by sequestering proteins. It is reported that it associate with PBC (prevalence 13%) and AIH (prevalence 4%).
DESCRIPTION
Expressed in insect Sf9 cells with total 906 AA. Mw: 100.5 KDa (calculated).
N-terminal 6xHis-tag and TEV cleavage site, 25 extra AA (highlighted).
Recombinant antigen for research use or manufacturing only.
SIZE
0.1 mg
INTRODUCTION
Key component of PML nuclear bodies that regulate a large number of cellular processes by facilitating post-translational modification of target proteins, promoting protein-protein contacts, or by sequestering proteins. It is reported that it associate with PBC (prevalence 13%) and AIH (prevalence 4%).
DESCRIPTION
Expressed in insect Sf9 cells with total 906 AA. Mw: 100.5 KDa (calculated).
N-terminal 6xHis-tag and TEV cleavage site, 25 extra AA (highlighted).
Recombinant antigen for research use or manufacturing only.